<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">24261578</PMID>
      <DateCompleted>
        <Year>2014</Year>
        <Month>04</Month>
        <Day>04</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1471-2377</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>13</Volume>
            <PubDate>
              <Year>2013</Year>
              <Month>Nov</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>BMC neurology</Title>
          <ISOAbbreviation>BMC Neurol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Chlamydia pneumoniae infection and cerebrovascular disease: a systematic review and meta-analysis.</ArticleTitle>
        <Pagination>
          <StartPage>183</StartPage>
          <MedlinePgn>183</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/1471-2377-13-183</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A wealth of published studies have been published on association between Chlamydia pneumoniae (C.pneumoniae) infection and cerebrovascular (CV) disease, but the results were inconsistent. This meta-analysis provides a systematic review of the available evidence from all serological and pathological studies of CV disease and C.pneumoniae.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A comprehensive research was conducted of MEDLINE, EMBASE, CNKI, WanFang technological periodical database and reference lists of articles to identify eligible case-control and cohort studies. Odds radio (OR) was calculated for each study outcome. Random effect model was used as pooling method and publication bias was estimated for the results.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifty-two published studies that met criteria were selected. In case control studies, an association between C.pneumoniae infection and CV disease was revealed by serum specific IgG (OR, 1.61; 95% CI: 1.34 to 1.94), serum IgA (OR, 2.33; 95% CI: 1.76 to 3.08) and PCR technique of C.pneumoniae in peripheral blood cells (OR, 1.90; 95% CI: 1.17 to 3.07). No significant association was found in serum anti-C.pneumonae IgM seropositivity or in-situ-detection of C.pneumoniae in arterial biopsies with CV disease. Subgroup analysis by available studies suggested that C.pneumoniae may paly a role in atherosclerotic stroke, but be less significant in stroke of cardioembolism or other etiologies.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Association between C.pneumoniae infection and CV disease depends on the analytical method adopted, which seems stronger with stroke due to large artery atherosclerosis. Establishing a causal relationship between C.peumoniae infection and CV disease will require more prospective studies with combination of techniques and stratified by etiological subtypes.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Juan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Affiliated Qianfoshan Hospital of Shandong University, 66 Jingshi Road, Jinan, Shandong province 250014, China. zhumeijia1818@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>Meijia</ForeName>
            <Initials>M</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ma</LastName>
            <ForeName>Gaoting</ForeName>
            <Initials>G</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Zhangning</ForeName>
            <Initials>Z</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Zhongwen</ForeName>
            <Initials>Z</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D017418">Meta-Analysis</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
          <PublicationType UI="D000078182">Systematic Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2013</Year>
          <Month>11</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>BMC Neurol</MedlineTA>
        <NlmUniqueID>100968555</NlmUniqueID>
        <ISSNLinking>1471-2377</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002561" MajorTopicYN="N">Cerebrovascular Disorders</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D023521" MajorTopicYN="N">Chlamydophila Infections</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016993" MajorTopicYN="N">Chlamydophila pneumoniae</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016206" MajorTopicYN="N">Databases, Bibliographic</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2013</Year>
          <Month>2</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2013</Year>
          <Month>11</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2013</Year>
          <Month>11</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2013</Year>
          <Month>11</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2014</Year>
          <Month>4</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">24261578</ArticleId>
        <ArticleId IdType="pmc">PMC4222774</ArticleId>
        <ArticleId IdType="doi">10.1186/1471-2377-13-183</ArticleId>
        <ArticleId IdType="pii">1471-2377-13-183</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>World Health Organization. The World Health Report 2008:Primary Health Care(Now More Than Ever) Switzerland: World Health Organization; 2008. </Citation>
        </Reference>
        <Reference>
          <Citation>Heuschmann PU, Neureiter D, Gesslein M, Craiovan B, Maass M, Faller G, Beck G, Neundoerfer B, Kolominsky-Rabas PL. Association between infection with helicobacter pylori and chlamydia pneumoniae and risk of ischemic stroke subtypes: results from a population-based case–control study. Stroke. 2001;32(10):2253–2258. doi: 10.1161/hs1001.097096.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/hs1001.097096</ArticleId>
            <ArticleId IdType="pubmed">11588309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bandaru VC, Boddu DB, Laxmi V, Neeraja M, Kaul S. Seroprevalence of chlamydia pneumoniae antibodies in stroke in young. Can J Neurol Sci. 2009;36(6):725–730.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19960750</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hasan ZN. Association of chlamydia pneumoniae serology and ischemic stroke. South Med J. 2011;104(5):319–321. doi: 10.1097/SMJ.0b013e3182114954.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/SMJ.0b013e3182114954</ArticleId>
            <ArticleId IdType="pubmed">21606708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bandaru VC, Boddu DB, Mridula KR, Akhila B, Alladi S, Laxmi V, Pathapati R, Neeraja M, Kaul S. Outcome of chlamydia pneumoniae associated acute ischemic stroke in elderly patients: a case–control study. Clin Neurol Neurosurg. 2012;114(2):120–123. doi: 10.1016/j.clineuro.2011.09.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clineuro.2011.09.016</ArticleId>
            <ArticleId IdType="pubmed">22030154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burillo A, Bouza E. Chlamydophila pneumoniae. Infect Dis Clin North Am. 2010;24(1):61–71. doi: 10.1016/j.idc.2009.10.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.idc.2009.10.002</ArticleId>
            <ArticleId IdType="pubmed">20171546</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, Huttunen JK, Valtonen V. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988;2(8618):983–986.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2902492</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elkind MS, Ramakrishnan P, Moon YP, Boden-Albala B, Liu KM, Spitalnik SL, Rundek T, Sacco RL, Paik MC. Infectious burden and risk of stroke: the northern Manhattan study. Arch Neurol. 2010;67(1):33–38. doi: 10.1001/archneurol.2009.271.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archneurol.2009.271</ArticleId>
            <ArticleId IdType="pmc">PMC2830860</ArticleId>
            <ArticleId IdType="pubmed">19901154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–2012. doi: 10.1001/jama.283.15.2008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.283.15.2008</ArticleId>
            <ArticleId IdType="pubmed">10789670</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188. doi: 10.1016/0197-2456(86)90046-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId>
            <ArticleId IdType="pubmed">3802833</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455–463. doi: 10.1111/j.0006-341X.2000.00455.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.0006-341X.2000.00455.x</ArticleId>
            <ArticleId IdType="pubmed">10877304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chan Carusone S, Smieja M, Molloy W, Goldsmith CH, Mahony J, Chernesky M, Gnarpe J, Standish T, Smith S, Loeb M. Lack of association between vascular dementia and chlamydia pneumoniae infection: a case–control study. BMC Neurol. 2004;4(1):15. doi: 10.1186/1471-2377-4-15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2377-4-15</ArticleId>
            <ArticleId IdType="pmc">PMC524508</ArticleId>
            <ArticleId IdType="pubmed">15476562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bandaru VC, Laxmi V, Neeraja M, Alladi S, Meena AK, Borgohain R, Keerthi AS, Kaul S. Chlamydia pneumoniae antibodies in various subtypes of ischemic stroke in Indian patients. J Neurol Sci. 2008;272(1–2):115–122.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18571201</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kis Z, Sas K, Gyulai Z, Treso B, Petrovay F, Kapusinszky B, Csire M, Endresz V, Burian K, Mandi Y. et al.Chronic infections and genetic factors in the development of ischemic stroke. New Microbiol. 2007;30(3):213–220.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17802898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alamowitch S, Labreuche J, Touboul PJ, Eb F, Amarenco P. Chlamydia pneumoniae seropositivity in aetiological subtypes of brain infarction and carotid atherosclerosis: a case control study. J Neurol Neurosurg Psychiatry. 2008;79(2):147–151. doi: 10.1136/jnnp.2007.126862.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp.2007.126862</ArticleId>
            <ArticleId IdType="pubmed">17911183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piechowski-Jozwiak B, Mickielewicz A, Gaciong Z, Berent H, Kwiecinski H. Elevated levels of anti-chlamydia pneumoniae IgA and IgG antibodies in young adults with ischemic stroke. Acta Neurol Scand. 2007;116(3):144–149. doi: 10.1111/j.1600-0404.2007.00819.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1600-0404.2007.00819.x</ArticleId>
            <ArticleId IdType="pubmed">17714326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Njamnshi AK, Blackett KN, Mbuagbaw JN, Gumedze F, Gupta S, Wiysonge CS. Chronic chlamydia pneumoniae infection and stroke in cameroon: a case–control study. Stroke. 2006;37(3):796–799. doi: 10.1161/01.STR.0000204223.04182.4a.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.STR.0000204223.04182.4a</ArticleId>
            <ArticleId IdType="pubmed">16469962</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elkind MS, Tondella ML, Feikin DR, Fields BS, Homma S, Di Tullio MR. Seropositivity to chlamydia pneumoniae is associated with risk of first ischemic stroke. Stroke. 2006;37(3):790–795. doi: 10.1161/01.STR.0000202624.89869.e9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.STR.0000202624.89869.e9</ArticleId>
            <ArticleId IdType="pubmed">16424371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anzini A, Cassone A, Rasura M, Ciervo A, Beccia M, Di Lisi F, Fieschi C. Chlamydia pneumoniae infection in young stroke patients: a case–control study. Eur J Neurol. 2004;11(5):321–327. doi: 10.1111/j.1468-1331.2004.00775.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1468-1331.2004.00775.x</ArticleId>
            <ArticleId IdType="pubmed">15142225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Voorend M, Faber CG, van der Ven AJ, Kessels F, Bruggeman CA, Lodder J. Chlamydia pneumoniae is a likely risk factor for ischemic stroke in young patients. J Stroke Cerebrovasc Dis. 2004;13(2):85–91. doi: 10.1016/j.jstrokecerebrovasdis.2004.02.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2004.02.003</ArticleId>
            <ArticleId IdType="pubmed">17903955</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bucurescu G, Stieritz DD. Evidence of an association between chlamydia pneumoniae and cerebrovascular accidents. Eur J Neurol. 2003;10(4):449–452. doi: 10.1046/j.1468-1331.2003.00605.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1468-1331.2003.00605.x</ArticleId>
            <ArticleId IdType="pubmed">12823500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ngeh J, Gupta S, Goodbourn C, Panayiotou B, McElligott G. Chlamydia pneumoniae in elderly patients with stroke (C-PEPS): a case–control study on the seroprevalence of chlamydia pneumoniae in elderly patients with acute cerebrovascular disease. Cerebrovasc Dis. 2003;15(1–2):11–16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12499705</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolf SC, Mayer O, Jurgens S, Vonthein R, Schultze G, Risler T, Brehm BR. Chlamydia pneumoniae IgA seropositivity is associated with increased risk for atherosclerotic vascular disease, myocardial infarction and stroke in dialysis patients. Clin Nephrol. 2003;59(4):273–279. doi: 10.5414/CNP59273.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5414/CNP59273</ArticleId>
            <ArticleId IdType="pubmed">12708567</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Madre JG, Garcia JL, Gonzalez RC, Montero JM, Paniagua EB, Escribano JR, Martinez JD, Cenjor RF. Association between seropositivity to chlamydia pneumoniae and acute ischaemic stroke. Eur J Neurol. 2002;9(3):303–306. doi: 10.1046/j.1468-1331.2002.00408.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1468-1331.2002.00408.x</ArticleId>
            <ArticleId IdType="pubmed">11985640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elkind MS, Lin IF, Grayston JT, Sacco RL. Chlamydia pneumoniae and the risk of first ischemic stroke : the Northern Manhattan stroke study. Stroke. 2000;31(7):1521–1525. doi: 10.1161/01.STR.31.7.1521.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.STR.31.7.1521</ArticleId>
            <ArticleId IdType="pubmed">10884447</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wimmer ML, Sandmann-Strupp R, Saikku P, Haberl RL. Association of chlamydial infection with cerebrovascular disease. Stroke. 1996;27(12):2207–2210. doi: 10.1161/01.STR.27.12.2207.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.STR.27.12.2207</ArticleId>
            <ArticleId IdType="pubmed">8969782</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnsen SP, Overvad K, Ostergaard L, Tjonneland A, Husted SE, Sorensen HT. Chlamydia pneumoniae seropositivity and risk of ischemic stroke: a nested case–control study. Eur J Epidemiol. 2005;20(1):59–65. doi: 10.1007/s10654-004-4341-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10654-004-4341-5</ArticleId>
            <ArticleId IdType="pubmed">15756905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smieja M, Gnarpe J, Lonn E, Gnarpe H, Olsson G, Yi Q, Dzavik V, McQueen M, Yusuf S. Multiple infections and subsequent cardiovascular events in the heart outcomes prevention evaluation (HOPE) study. Circulation. 2003;107(2):251–257. doi: 10.1161/01.CIR.0000044940.65226.1F.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.CIR.0000044940.65226.1F</ArticleId>
            <ArticleId IdType="pubmed">12538424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coles KA, Knuiman MW, Plant AJ, Riley TV, Smith DW, Divitini ML. A prospective study of infection and cardiovascular diseases: the busselton health study. Eur J Cardiovasc Prev Rehabil. 2003;10(4):278–282. doi: 10.1097/00149831-200308000-00010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00149831-200308000-00010</ArticleId>
            <ArticleId IdType="pubmed">14555883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tanne D, Haim M, Boyko V, Goldbourt U, Reshef T, Adler Y, Brunner D, Mekori YA, Behar S. Prospective study of chlamydia pneumoniae IgG and IgA seropositivity and risk of incident ischemic stroke. Cerebrovasc Dis. 2003;16(2):166–170. doi: 10.1159/000070597.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000070597</ArticleId>
            <ArticleId IdType="pubmed">12792175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gerdes VE, Verkooyen RP, Kwa VI, de Groot E, van Gorp EC, ten Cate H, Brandjes DP, Buller HR. Chlamydial LPS antibodies, intima-media thickness and ischemic events in patients with established atherosclerosis. Atherosclerosis. 2003;167(1):65–71. doi: 10.1016/S0021-9150(02)00150-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0021-9150(02)00150-8</ArticleId>
            <ArticleId IdType="pubmed">12618269</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Glader CA, Stegmayr B, Boman J, Stenlund H, Weinehall L, Hallmans G, Dahlen GH. Chlamydia pneumoniae antibodies and high lipoprotein(a) levels do not predict ischemic cerebral infarctions. Results from a nested case–control study in Northern Sweden. Stroke. 1999;30(10):2013–2018. doi: 10.1161/01.STR.30.10.2013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.STR.30.10.2013</ArticleId>
            <ArticleId IdType="pubmed">10512900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Apfalter P, Barousch W, Nehr M, Willinger B, Rotter M, Hirschl AM. No evidence of involvement of chlamydia pneumoniae in severe cerebrovascular atherosclerosis by means of quantitative real-time polymerase chain reaction. Stroke. 2004;35(9):2024–2028. doi: 10.1161/01.STR.0000137765.64705.d8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.STR.0000137765.64705.d8</ArticleId>
            <ArticleId IdType="pubmed">15256684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>LaBiche R, Koziol D, Quinn TC, Gaydos C, Azhar S, Ketron G, Sood S, DeGraba TJ. Presence of chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque. Stroke. 2001;32(4):855–860. doi: 10.1161/01.STR.32.4.855.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.STR.32.4.855</ArticleId>
            <ArticleId IdType="pubmed">11283382</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu A, Xu J, Xi Z. Serum chlamydia pneunoniae antibodies and high-sentive C-reactive protein in patients with stroke. Zhongguo linchuang Kangfu. 2006;10(38):85–87.</Citation>
        </Reference>
        <Reference>
          <Citation>Kenina V, Auce P, Millers A. The relationship between seropositivity against chlamydia pneumoniae and stroke and its subtypes in a Latvian population. Medicina (Kaunas) 2011;47(12):657–660.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22370464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen YJ, Zhang XH, Zou W, Liu SY, Zhang P. Effect of chlamydia pneunoniae infection on serum CRP and HCY in ischemic stroke patients. Guangdong Medical Journal. 2010;31(9):1151–1152.</Citation>
        </Reference>
        <Reference>
          <Citation>Tiszlavicz Z, Somogyvari F, Kocsis AK, Szolnoki Z, Sztriha LK, Kis Z, Vecsei L, Mandi Y. Relevance of the genetic polymorphism of NOD1 in chlamydia pneumoniae seropositive stroke patients. Eur J Neurol. 2009;16(11):1224–1229. doi: 10.1111/j.1468-1331.2009.02698.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1468-1331.2009.02698.x</ArticleId>
            <ArticleId IdType="pubmed">19538217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alavi SM, Ahmadi F, Abeshtan A. Is Chlamydia pneumoniae seropositivity associated with atherothrombotic cerebrovascular infarction? J Infect Public Health. 2009;2(2):96–99. doi: 10.1016/j.jiph.2009.04.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jiph.2009.04.001</ArticleId>
            <ArticleId IdType="pubmed">20701868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin TM, Chen CH, Wu HL, Wang CH, Chen YL, Eng HL. The association of C (−260)–T polymorphism in CD14 promoter and chlamydia pneumoniae infection in ischemic stroke patients. Am J Clin Pathol. 2008;130(4):595–601. doi: 10.1309/KBC4HHCDBW7D1JY6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1309/KBC4HHCDBW7D1JY6</ArticleId>
            <ArticleId IdType="pubmed">18794053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu J, Yan YA, Jia TJ. Association of MBL and chlamydia pneunoniae infection with ischemic cerebrovascular disease. Acta Academiae Medicinae Jiangxi. 2008;48(4):86–89.</Citation>
        </Reference>
        <Reference>
          <Citation>Chi LQ, Wang P, Zhang C. The clinical study of relationships between inflammation, chlamydia pneunoniae infection and cerebral infaction. Chin J Postgrad Med. 2007;30(9):14–16.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu JX, Yan PJ, Mei YW. Association between chlamydia pneunoniae infection and cerebral infaction. Chin J Clin Rehabil. 2006;10(14):94–97.</Citation>
        </Reference>
        <Reference>
          <Citation>Chen L, Zhou YY, Ma WL, Liu P. Association between high-sensitivity C-reaction protein, chlamydia pneunoniae infection and carotid artery atherosclerosis and ischemic stroke. Chin J Geriatr Heart Brain Vessel Dis. 2006;8(5):319–321.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu AM, Xu J, yU ZY. Serum chlamydia pneunoniae antibodies and high-sentitive C-reactive protein in patients with stroke. Chin J Clin Rehabil. 2006;10(38):85–87.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhou B, Shi JP, Fu LY, Li RB, Cao XH, Yang ZQ, Li H. The statistical analysis of association between serum level of chlamydia pneunonia immunoglobulin A antibody and the attack of ischemic stroke. Chin J Pract Internal Med. 2007;27(4):296–299.</Citation>
        </Reference>
        <Reference>
          <Citation>Fl L. Measurement of antibody to chlamydia pneunoniae in serum of patients with cerebral vascular disease and study of pathogenesis. J Brain Neurol. 2004;12(5):377–378.</Citation>
        </Reference>
        <Reference>
          <Citation>Kawamoto R, Kajiwara T, Oka Y, Takagi Y. An association between an antibody against chlamydia pneumoniae and ischemic stroke in elderly Japanese. Intern Med. 2003;42(7):571–575. doi: 10.2169/internalmedicine.42.571.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2169/internalmedicine.42.571</ArticleId>
            <ArticleId IdType="pubmed">12879948</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sirmatel F, Neyal Muftuoglu M, Tahtaci N, Neyal A, Sirmatel O, Bulbul B. Chlamydia pneumoniae seropositivity in patients with cerebral ischemic attack with or without silent brain infarcts. Ups J Med Sci. 2003;108(3):205–212. doi: 10.3109/2000-1967-114.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/2000-1967-114</ArticleId>
            <ArticleId IdType="pubmed">15000458</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou R, Pan SZ, Lai SH, Huang RH. The correlation between chlamydia pneunoniae and stroke. Clin Med Chin China. 2003;19(10):881–882.</Citation>
        </Reference>
        <Reference>
          <Citation>Tarnacka B, Gromadzka G, Czlonkowska A. Increased circulating immune complexes in acute stroke: the triggering role of Chlamydia pneumoniae and cytomegalovirus. Stroke. 2002;33(4):936–940. doi: 10.1161/01.STR.0000014562.75483.6B.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.STR.0000014562.75483.6B</ArticleId>
            <ArticleId IdType="pubmed">11935040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sessa R, Di Pietro M, Schiavoni G, Santino I, Benedetti-Valentini F, Perna R, Romano S, del Piano M. Chlamydia pneumoniae DNA in patients with symptomatic carotid atherosclerotic disease. J Vasc Surg. 2003;37(5):1027–1031. doi: 10.1067/mva.2003.200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1067/mva.2003.200</ArticleId>
            <ArticleId IdType="pubmed">12756349</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Katsenis C, Kouskouni E, Kolokotronis L, Rizos D, Dimakakos P. The significance of chlamydia pneumoniae in symptomatic carotid stenosis. Angiology. 2001;52(9):615–619. doi: 10.1177/000331970105200905.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/000331970105200905</ArticleId>
            <ArticleId IdType="pubmed">11570660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gagliardi RJ, Caiaffa-Filho HH. Chlamydia pneumoniae and stroke: is there a direct relationship? Arq Neuropsiquiatr. 2009;67(3A):600–604. doi: 10.1590/S0004-282X2009000400005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S0004-282X2009000400005</ArticleId>
            <ArticleId IdType="pubmed">19722034</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muller J, Moller DS, Kjaer M, Nyvad O, Larsen NA, Pedersen EB. Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in healthy control subjects and patients with diabetes mellitus, acute coronary syndrome, stroke, and arterial hypertension. Scand J Infect Dis. 2003;35(10):704–712. doi: 10.1080/00365540310016538.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/00365540310016538</ArticleId>
            <ArticleId IdType="pubmed">14606608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wohlschlaeger J, Wimmer ML, Nagler DK, Haberl R, Weis S. Identification of chlamydia pneumoniae in intracranial and extracranial arteries in patients with stroke and in controls: combined immunohistochemical and polymerase chain reaction analyses. Hum Pathol. 2005;36(4):395–402. doi: 10.1016/j.humpath.2005.02.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.humpath.2005.02.003</ArticleId>
            <ArticleId IdType="pubmed">15892001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neureiter D, Heuschmann P, Stintzing S, Kolominsky-Rabas P, Barbera L, Jung A, Ocker M, Maass M, Faller G, Kirchner T. Detection of chlamydia pneumoniae but not of helicobacter pylori in symptomatic atherosclerotic carotids associated with enhanced serum antibodies, inflammation and apoptosis rate. Atherosclerosis. 2003;168(1):153–162. doi: 10.1016/S0021-9150(03)00085-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0021-9150(03)00085-6</ArticleId>
            <ArticleId IdType="pubmed">12732399</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lastas A, Graziene V, Barkauskas E, Salkus G, Rimkevicius A. Carotid artery atherosclerotic plaque: clinical and morphological-immunohistochemical correlation. Med Sci Monit. 2004;10(11):CR606–614.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15507852</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jahromi BS, Hill MD, Holmes K, Hutchison S, Tucker WS, Chiu B. Chlamydia pneumoniae and atherosclerosis following carotid endarterectomy. Can J Neurol Sci. 2003;30(4):333–339.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14672265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bloemenkamp DG, Mali WP, Visseren FL, van der Graaf Y. Meta-analysis of sero-epidemiologic studies of the relation between chlamydia pneumoniae and atherosclerosis: does study design influence results? Am Heart J. 2003;145(3):409–417. doi: 10.1067/mhj.2003.20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1067/mhj.2003.20</ArticleId>
            <ArticleId IdType="pubmed">12660662</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dowell SF, Peeling RW, Boman J, Carlone GM, Fields BS, Guarner J, Hammerschlag MR, Jackson LA, Kuo CC, Maass M. et al.Standardizing chlamydia pneumoniae assays: recommendations from the centers for disease control and prevention (USA) and the laboratory centre for disease control (canada) Clin Infect Dis. 2001;33(4):492–503. doi: 10.1086/322632.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/322632</ArticleId>
            <ArticleId IdType="pubmed">11462186</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bedard L, Paquette N, Cionti Bas M, Aube M, Letourneau J. [The daily public health nursing practice: the montreal infectious diseases unit as an example] Sante Publique. 2004;16(2):313–328. doi: 10.3917/spub.042.0313.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3917/spub.042.0313</ArticleId>
            <ArticleId IdType="pubmed">15360184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Westendorp WF, Nederkoorn PJ, Vermeij JD, Dijkgraaf MG, van de Beek D. Post-stroke infection: a systematic review and meta-analysis. BMC Neurol. 2011;11:110. doi: 10.1186/1471-2377-11-110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2377-11-110</ArticleId>
            <ArticleId IdType="pmc">PMC3185266</ArticleId>
            <ArticleId IdType="pubmed">21933425</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hedayat DK, Jebeli M, Mandegar MH, Bagheri J, Nabavi SA, Eghtesadi-Araghi P, Mohammadzadeh R, Darehzereshki A, Chitsaz S, Abbasi A. The association between chlamydia pneumoniae DNA in arherosclerotic plaque and major risk factors in patients undergoing coronary artery bypass grafting. Kardiol Pol. 2009;67(9):981–986.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19838954</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hvidsten D, Halvorsen DS, Berdal BP, Gutteberg TJ. Chlamydophila pneumoniae diagnostics: importance of methodology in relation to timing of sampling. Clin Microbiol Infect. 2009;15(1):42–49. doi: 10.1111/j.1469-0691.2008.02075.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1469-0691.2008.02075.x</ArticleId>
            <ArticleId IdType="pubmed">19046171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gan R, Sacco RL, Kargman DE, Roberts JK, Boden-Albala B, Gu Q. Testing the validity of the lacunar hypothesis: the Northern Manhattan stroke study experience. Neurology. 1997;48(5):1204–1211. doi: 10.1212/WNL.48.5.1204.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.48.5.1204</ArticleId>
            <ArticleId IdType="pubmed">9153444</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sawayama Y, Tatsukawa M, Okada K, Maeda N, Shimizu C, Kikuchi K, Hayashi J. Association of chlamydia pneumoniae antibody with the cholesterol-lowering effect of statins. Atherosclerosis. 2003;171(2):281–285. doi: 10.1016/j.atherosclerosis.2003.08.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.atherosclerosis.2003.08.006</ArticleId>
            <ArticleId IdType="pubmed">14644398</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grau AJ, Buggle F, Ziegler C, Schwarz W, Meuser J, Tasman AJ, Buhler A, Benesch C, Becher H, Hacke W. Association between acute cerebrovascular ischemia and chronic and recurrent infection. Stroke. 1997;28(9):1724–1729. doi: 10.1161/01.STR.28.9.1724.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.STR.28.9.1724</ArticleId>
            <ArticleId IdType="pubmed">9303015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mousa A, Al-Zaki A, Taha S, Bakhiet M. Induction of interleukin-18 in atherosclerotic patients: a role for chlamydia pneumoniae. Med Princ Pract. 2009;18(2):105–110. doi: 10.1159/000189807.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000189807</ArticleId>
            <ArticleId IdType="pubmed">19204428</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takaoka N, Campbell LA, Lee A, Rosenfeld ME, Kuo CC. Chlamydia pneumoniae infection increases adherence of mouse macrophages to mouse endothelial cells in vitro and to aortas ex vivo. Infect Immun. 2008;76(2):510–514. doi: 10.1128/IAI.01267-07.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.01267-07</ArticleId>
            <ArticleId IdType="pmc">PMC2223438</ArticleId>
            <ArticleId IdType="pubmed">18070891</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalayoglu MV, Libby P, Byrne GI. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA. 2002;288(21):2724–2731. doi: 10.1001/jama.288.21.2724.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.288.21.2724</ArticleId>
            <ArticleId IdType="pubmed">12460096</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
